Chandal, N.; Sharma, N.; Cernicchi, G.; Felicetti, T.; Rondini, T.; Acito, M.; Nandanwar, H.; Sabatini, S.
In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains. Antibiotics 2025, 14, 339.
https://doi.org/10.3390/antibiotics14040339
AMA Style
Chandal N, Sharma N, Cernicchi G, Felicetti T, Rondini T, Acito M, Nandanwar H, Sabatini S.
In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains. Antibiotics. 2025; 14(4):339.
https://doi.org/10.3390/antibiotics14040339
Chicago/Turabian Style
Chandal, Nishtha, Nidhi Sharma, Giada Cernicchi, Tommaso Felicetti, Tommaso Rondini, Mattia Acito, Hemraj Nandanwar, and Stefano Sabatini.
2025. "In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains" Antibiotics 14, no. 4: 339.
https://doi.org/10.3390/antibiotics14040339
APA Style
Chandal, N., Sharma, N., Cernicchi, G., Felicetti, T., Rondini, T., Acito, M., Nandanwar, H., & Sabatini, S.
(2025). In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains. Antibiotics, 14(4), 339.
https://doi.org/10.3390/antibiotics14040339
